Advisory Alpha, LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 217 filers reported holding IMMUNOMEDICS INC in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.6%.

Quarter-by-quarter ownership
Advisory Alpha, LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$3,000
-99.7%
400.0%0.00%
Q1 2020$1,047,000
+35.6%
400.0%0.00%
Q4 2019$772,000
+40.4%
400.0%0.00%
Q3 2019$550,000
-4.0%
400.0%0.00%
Q1 2019$573,000400.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 1,711,067$2,943,0001.70%
J.P. Turner & Co Capital Mnagement, LLC 248,625$428,0000.44%
Orbimed Advisors 3,323,000$5,716,0000.06%
BALYASNY ASSET MANAGEMENT L.P. 2,004,078$3,447,0000.02%
WOLVERINE ASSET MANAGEMENT LLC 5,870$1,018,0000.02%
SIGNET FINANCIAL MANAGEMENT, LLC 44,675$77,0000.02%
SVB WEALTH LLC 195,000$335,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 288,900$497,0000.01%
J.P. Turner & Co Capital Mnagement, LLC 153,900$8,0000.01%
BALYASNY ASSET MANAGEMENT L.P. 640,400$1,101,0000.01%
View complete list of IMMUNOMEDICS INC shareholders